News
Nkarta – Allogeneic CAR Natural Killer (NK) Cell Therapy
Paul Hastings, CEO of Nkarta Therapeutics discusses results from their NKX101 study, an allogeneic CAR Natural Killer (NK) cell therapy, in patients wit...